ITI is a program of The Task Force for Global Health.
ITI Works Closely with Trachoma-Endemic Communities and Founding Partners to Stop Blindness from Trachoma
ITI also is a founding member of the International Coalition for Trachoma Control, the coalition of non-governmental organizations supporting trachoma control globally.
In 1998, Pfizer Inc. and the Edna McConnell Clark Foundation, founded the ITI as an international nongovernmental organization dedicated solely to the elimination of trachoma. ITI manages Pfizer’s donation of Zithromax® to prevent and treat trachoma. To date, Pfizer has donated more than half a billion Zithromax® treatments through ITI. In 2016, 25 countries received a Zithromax® donation.
Pfizer is one of the world’s leading pharmaceutical companies. Pfizer applies science and global resources to bring therapies to people that extend and significantly improve their lives. For more than 150 years, Pfizer has worked to make a difference for all who rely on them.
In April 2009, ITI joined forces with the Task Force for Global Health, a not-for-profit public health organization, to leverage resources and significantly increase efforts to eliminate blinding trachoma. The Task Force and ITI are based in Decatur, Georgia, U.S. ITI also has an office in Ethiopia.
The Task Force for Global Health has a 30-year history of improving the lives of millions of people around the world. Working with a broad network of public and private sector partners, the Task Force manages an array of initiatives focused on neglected tropical diseases, immunization and vaccines, and health systems strengthening.